PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 198 filers reported holding PDL BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | +66.7% | 3,169 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 3,169 | +0.3% | 0.00% | – |
| Q2 2019 | $9,000 | -86.6% | 3,161 | -82.6% | 0.00% | -100.0% |
| Q1 2019 | $67,000 | +28.8% | 18,125 | 0.0% | 0.00% | – |
| Q4 2018 | $52,000 | +4.0% | 18,125 | -5.3% | 0.00% | – |
| Q3 2018 | $50,000 | -29.6% | 19,142 | -20.7% | 0.00% | -100.0% |
| Q2 2018 | $71,000 | 0.0% | 24,142 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $71,000 | +22.4% | 24,142 | +14.9% | 0.00% | 0.0% |
| Q4 2017 | $58,000 | -18.3% | 21,017 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $71,000 | +36.5% | 21,017 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $52,000 | +8.3% | 21,017 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $48,000 | +1500.0% | 21,017 | +1329.7% | 0.00% | – |
| Q4 2016 | $3,000 | -92.7% | 1,470 | -87.9% | 0.00% | -100.0% |
| Q3 2016 | $41,000 | +2.5% | 12,170 | -3.5% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | 0.0% | 12,613 | +6.3% | 0.00% | 0.0% |
| Q1 2016 | $40,000 | -34.4% | 11,869 | -31.3% | 0.00% | 0.0% |
| Q4 2015 | $61,000 | -39.6% | 17,275 | -14.0% | 0.00% | -50.0% |
| Q3 2015 | $101,000 | -16.5% | 20,083 | +5.9% | 0.00% | 0.0% |
| Q2 2015 | $121,000 | -8.3% | 18,956 | +0.1% | 0.00% | -33.3% |
| Q1 2015 | $132,000 | -1.5% | 18,934 | +8.8% | 0.00% | 0.0% |
| Q4 2014 | $134,000 | +50.6% | 17,395 | +45.6% | 0.00% | +50.0% |
| Q3 2014 | $89,000 | -16.8% | 11,949 | +7.7% | 0.00% | -33.3% |
| Q2 2014 | $107,000 | -0.9% | 11,092 | -14.9% | 0.00% | 0.0% |
| Q1 2014 | $108,000 | -9.2% | 13,036 | -7.7% | 0.00% | -25.0% |
| Q4 2013 | $119,000 | -4.8% | 14,116 | -9.3% | 0.00% | 0.0% |
| Q3 2013 | $125,000 | +2.5% | 15,570 | -1.0% | 0.00% | 0.0% |
| Q2 2013 | $122,000 | – | 15,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |